|
Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified health advice, travels to or treatment by using a genuine physician. We are not physicians. Always consult your dr. on Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen conditions. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen Clinical research trials and Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen health trials occur in hundreds of cities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectivity of new drugs. The propose of the studies / undertakings is to resolve certain human health questions. Clinical trials are a popular means for physicians, government agencies, and private sector companies to locate treatments for all sorts of conditions, including Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen. Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen Clinical Trials and other clinical trials permit volunteers to acquire medical treatment choices before they are available to the masses. Some times the test subjects obtain professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen clinical trial. Participants oftentimes recieve the most expert healthcare available for their Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen condition. Hazards are a reality, however, and can include extra or frequent physician visits, health risks (potentially life-endangering), and/or the treatment being uneffective. Trials are federally governed with rigorous guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "T" Clinical Trials Conditions > Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen  Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen
Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen
For Condition: HIV Infections,Tuberculosis
Status: Suspended
Sponsor(s): Centers for Disease Control and Prevention , Department of Veterans Affairs
Synopsis: Primary objective: To determine the rate of confirmed treatment failure and relapse with an intermittent rifabutin-based regimen for the treatment of isoniazid and rifamycin-susceptible HIV-related tuberculosis.
Details:
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: - Patients with HIV-related tuberculosis
Total Enrollment:
Location and Contact Information:
University of British Columbia
Vancouver, British Columbia, Canada V5Z 4R4
Canada
New York University School of Medicine
New York City, New York, 10016
United States
Chicago VA Medical Center (Lakeside)
Chicago, Illinois, 60611
United States
University of Manitoba
Winnipeg, Manitoba, CANADA R3A 1R8
Canada
Carolinas Medical Center
Charlotte, North Carolina, 28203
United States
Audi L. Murphy VA Hospital
San Antonio, Texas, 78284
United States
Denver Department of Public Health and Hospitals
Denver, Colorado, 80204
United States
University of North Texas Health Science Center
Ft. Worth, Texas, 76107-2699
United States
Harlem Hospital Center
New York City, New York, 10037
United States
Thomas Street Clinic
Houston, Texas, 77009
United States
Montreal Chest Institute McGill University
Montreal, Quebec, H2X 2P4Pq Canada
Canada
New Jersey Medical School
Newark, New Jersey, 07107-3001
United States
LA County/USC Medical Center
Los Angeles, California, 90033
United States
Duke University Medical Center
Durham, North Carolina, 34222
United States
Hines VA Medical Center
Hines, Illinois, 60141
United States
Johns Hopkins University School of Medicine
Baltimore, Maryland, 21287-0003
United States
Boston Medical Center
Boston, Massachusetts, 02118
United States
Washington, D.C. VAMC
Washington D.C., District of Columbia, 20422
United States
Seattle King County Health Department
Seattle, Washington, 98104
United States
Central Arkansas Veterans Health System
Little Rock, Arkansas, 72205
United States
Nashville VA Medical Center
Nashville, Tennessee, 37212-2637
United States
Columbia University/Presbyterian Medical Center
New York City, New York, 10032
United States
University of California, San Francisco
San Francisco, California, 94110
United States
Additional Information:
Study ID Numbers: 2174; 23
Study Start Date:
Record last reviewed: March 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00023361
Other Hiv Infections Studies:
1. A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines in Vaccinia-Naive Individuals
2. A Pilot Study of the Patterns of Cellular Gene Expression in HIV-1 Patients Following Clinical Events Which Increase Plasma Virus Concentrations
3. A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.
4. A Study of Nitazoxanide in the Treatment of AIDS-Related Diarrhea
5. Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients
Related Studies:
Other HIV Infections Clinical Trials
Other California Clinical Trials
Other Los Angeles Clinical Trials
Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen
|
|
|
|
|
|
|
|
